With the analysis among 295 patents, we discovered top 76 key players by total patent application. Io Therapeutics, Inc., Altergon SA, Janssen Biotech are dominant in this area. They take 37.29% of the total patent filing.
California, United States
Patent: 72
F. Hoffmann-La Roche Ltd.
Madrigal Pharmaceuticals, Inc.
Pennsylvania, United States
Patent: 15
NEWPORT, United Kingdom
Patent: 15
Spectrix Therapeutics LLC
Texas, United States
Patent: 12
The Board of Regents of The University of Texas System
Texas, United States
Patent: 10
Galmed Research & Development Ltd.
Kylonova (Xiamen) Biopharma Co., Ltd.
Fujian Sheng, China
Patent: 8
With the analysis among 20 patents, we discovered top 5 start-ups by total patent application. Spectrix Therapeutics LLC, Shenzhen Tajirui Biomedical Co. Ltd., Institut National de la Santé et de la Recherche Médicale are active in this area.
Spectrix Therapeutics LLC
Texas, United States
Patent: 12
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 5
Institut National de la Santé et de la Recherche Médicale
Autobahn Therapeutics, Inc.
California, United States
Patent: 1
Shanghai Shi, China
Patent: 1
With the analysis among related 269 patents applied in the last 5 years. We discover 74 most active companies in this area. The fast-growing Io Therapeutics, Inc., NanoPharm Ltd., Altergon SA take 25.28% of patent filing during this period.
California, United States
Patent: 44
NEWPORT, United Kingdom
Patent: 12
Galmed Research & Development Ltd.
The Board of Regents of The University of Texas System
Texas, United States
Patent: 10
Kylonova (Xiamen) Biopharma Co., Ltd.
Fujian Sheng, China
Patent: 8
Madrigal Pharmaceuticals, Inc.
Pennsylvania, United States
Patent: 6
Spectrix Therapeutics LLC
Texas, United States
Patent: 6
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 5
With the analysis among related 269 patents in last 5 years, we discover 65 new entrants. Galmed Research & Development Ltd., The Board of Regents of The University of Texas System, Kylonova (Xiamen) Biopharma Co., Ltd. are the most active new entrants in this area.
Galmed Research & Development Ltd.
The Board of Regents of The University of Texas System
Texas, United States
Patent: 10
Kylonova (Xiamen) Biopharma Co., Ltd.
Fujian Sheng, China
Patent: 8
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 5
Shanghai Shangyao Ruier Pharmaceutical Co., Ltd.
Sumitomo Pharmaceuticals Co., Ltd.
Sumitomo Chemical Co., Ltd.
Shenzhen Chipscreen Biosciences Co., Ltd.
Guangdong Sheng, China
Patent: 4
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine
undefined undefined
Patent: 3
With the analysis among 72 patents, we discovered top 23 universities and scientific research institutions by total patent application. Boston University, Peking University, The Salk Institute for Biological Studies are dominant in this area. They take 34.72% of the total patent filing.
Massachusetts, United States
Patent: 4
Beijing Shi, China
Patent: 3
The Salk Institute for Biological Studies
California, United States
Patent: 3
Connecticut, United States
Patent: 2
Victoria, Australia
Patent: 2
Georgia, United States
Patent: 2
Université d'Aix-Marseille
Albany College of Pharmacy & Health Sciences
New York, United States
Patent: 2
Chengdu University of Traditional Chinese Medicine
Sichuan Sheng, China
Patent: 2
New York, United States
Patent: 1